This is a retrospective and prospective multi-center observational study of the management and outcomes of BTAI. This study will include patients who meet the registry inclusion criteria as documented in EPIC and chart review will start from January 2019 and December 2028. Data and endpoints will be observational and involve no prescribed therapeutic interventions or alterations in patient care. Institutions and providers will conduct normal diagnosis, management, and surveillance procedures without interference of this study.
This is a retrospective and prospective multi-center observational study of the management and outcomes of BTAI. This study will include patients who meet the registry inclusion criteria as documented in EPIC and chart review will start from January 2019 and December 2028. Data and endpoints will be observational and involve no prescribed therapeutic interventions or alterations in patient care. Institutions and providers will conduct normal diagnosis, management, and surveillance procedures without interference of this study.
Study Type
OBSERVATIONAL
Enrollment
300
Methodist Dallas Medical Center
Dallas, Texas, United States
The primary objective of this study is to establish a database of information that will allow the presentation, diagnosis, management, and outcomes of BTAI to be analyzed.
Time frame: January 2019 and December 2028
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.